标普生物科技LOF(161127)
动态评分: 4.62分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2019-06-30 | HALO | 奥洛兹美医疗 | 68.96 | 0.59% |
2019-06-30 | CHRS | Coherus BioSciences Inc | 68.29 | 0.58% |
2019-06-30 | ANAB | AnaptysBio Inc | 66.48 | 0.57% |
2019-06-30 | OPK | OPKO健康 | 66.31 | 0.57% |
2019-06-30 | RARX | Ra Pharmaceuticals Inc | 67 | 0.57% |
2019-06-30 | XLRN | Acceleron Pharma Inc | 65.1 | 0.56% |
2019-06-30 | FATE | Fate Therapeutics Inc | 64.06 | 0.55% |
2019-06-30 | RDUS | Radius Health Inc | 64.44 | 0.55% |
2019-06-30 | NTRA | Natera Inc | 62.61 | 0.54% |
2019-06-30 | CARA | Cara Therapeutics Inc | 62.05 | 0.53% |
2019-06-30 | ALLO | Allogene Therapeutics Inc | 60.93 | 0.52% |
2019-06-30 | AIMT | Aimmune Therapeutics Inc | 58.55 | 0.5% |
2019-06-30 | PGEN | Precigen Inc | 57.34 | 0.49% |
2019-06-30 | VCEL | Vericel Corp | 56.31 | 0.48% |
2019-06-30 | ALDR | Alder BioPharmaceuticals Inc | 55.22 | 0.47% |
2019-06-30 | VNDA | Vanda Pharmaceuticals Inc | 53.63 | 0.46% |
2019-06-30 | GTHX | G1 Therapeutics Inc | 52.32 | 0.45% |
2019-06-30 | VYGR | Voyager Therapeutics Inc | 50.97 | 0.44% |
2019-06-30 | EPZM | Epizyme Inc | 50.02 | 0.43% |
2019-06-30 | APLS | Apellis Pharmaceuticals Inc | 48.73 | 0.42% |
公告&资料
